Kronox Lab Sciences IPO Details
| IPO Size | 130.15 |
| Price Range | ₹129 to ₹136 |
| Retail Quota | 35% |
| QIB Quota | 50% |
| NII Quota | 15% |
| Employee Discount | -- |
| Listing at | NSE and BSE |
| Minimum Quantity | 110 |
| Investment (cut-off price) | ₹14,960 |
| Pre IPO Promotor Holding | 99.98% |
| Post IPO Promotor Holding | 74.21% |
| DHRP Draft | Click Here |
| RHP Draft | Click Here |
| Anchor Investors List | Click Here |
Kronox Lab Sciences IPO Timelines
03/06/2024
Start Date05/06/2024
End Date07/06/2024
Refund Initiation07/06/2024
Credit of Shares to Demat Ac10/06/2024
Listing DateKronox Lab Sciences IPO Lot Size
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 110 | ₹14,960 |
| Retail Maximum | 13 | 1430 | ₹194,480 |
| S-HNI Minimum | 14 | 1540 | ₹209,440 |
| B-HNI Minimum | 67 | 7370 | ₹1,002,320 |
Kronox Lab Sciences IPO Subscription Status
| QIB | NII | Retail | EMP | Total |
|---|---|---|---|---|
| 3.39 x | 53.07 x | 24.89 x | -- | 24.80 x |
IPO Performance on Listing Day
| Opening Price | Closing Price | Day High | Day Low |
|---|---|---|---|
| ₹164.95 | ₹159.30 | ₹165.60 | ₹156.70 |
Kronox Lab Sciences IPO Company Financials
| Year | Total Income | Total Expense | PAT |
|---|---|---|---|
| FY 2021 | ₹63.24 | ₹50.02 | ₹9.73 |
| FY 2022 | ₹83.34 | ₹64.99 | ₹13.63 |
| FY 2023 | ₹97.50 | ₹75.17 | ₹16.62 |
| FY 2024 (9M) | ₹68.44 | ₹48.22 | ₹15.47 |
About Company
Kronox Lab Sciences, incorporated in 2008, manufactures high-quality fine chemicals for diverse end-user industries. The company’s chemicals are used in various applications, such as manufacturing APIs, pharmaceutical formulation, scientific research, nutraceuticals, biotech applications, agrochemical formulations, personal care products, metal refineries, and animal health products.
Kronox offers over 185 products, including phosphate, sulphate, acetate, chloride, citrate, nitrates, nitrites, carbonate, EDTA derivatives, hydroxide, succinate, gluconate, and others. It exports its products to countries such as the United States, Argentina, Mexico, Australia, Egypt, Spain, Turkey, UK, UAE, and China. Kronox had three manufacturing facilities in Vadodara, Gujarat near to the seaports of Mundra, Kandla, Hazira, and Nhava Sheva.
| Incorporation Date | Sector | Managing Director |
|---|---|---|
| 2008 | Chemicals | Mr. Jogindersingh Jaswal |
Know Before Investing
Kronox Lab Sciences IPO Strengths
- Wide range of products finding applications in diversified end-user industries.
- High entry and exit barriers due to long customer approval cycles and strict product standards.
Kronox Lab Sciences IPO Risks
- Products of the company are supplied in limited quantities and for specific use by application industries thus any change in the requirement of its products may affect the business.
- The majority of sales of products are concentrated in industries viz. Pharmaceuticals and Scientific Research and Laboratory Testing.
Swot Analysis for Kronox Lab Sciences IPO
Strengths
Weaknesses
Opportunities
Threats
Contact Details of IXIGO
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: [email protected]
Website: https://kosmic.kfintech.com/ipostatus/
Company Details
Kronox Lab Sciences Limited
Block No. 353,
Village Ekalbara, Padra,
Vadodara-391440
Phone: +91 26 6224 4077/88
Email: [email protected]
Website: https://www.kronoxlabsciences.com/
IPO Registar Details
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: [email protected]
Website: https://kosmic.kfintech.com/ipostatus/
FAQs
The key objectives of Kronox Lab Sciences IPO are:
- Facilitate an Offer for Sale of up to 95,70,000 equity shares by the promoter selling shareholders
- Achieve the benefits of listing the company’s equity shares on stock exchanges, including:
- Enhancing visibility and brand image
- Providing liquidity to existing shareholders
- Creating a public market for equity shares in India